Comunicati.net - Comunicati pubblicati - Comune di Ferrara Comunicati.net - Comunicati pubblicati - Comune di Ferrara Sun, 11 Apr 2021 17:16:13 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/1 The Molecular Grade Plates Market To Witness An Extensive Growth With A CAGR Of 4.1% Fri, 09 Apr 2021 13:40:19 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701550.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701550.html persistencemarketresearch persistencemarketresearch

Chronic diseases such as cancer, viral infections, and cardio vascular disorders are constantly increasing across the world. Polymerase chain reaction (PCR) is a broadly-used test for the diagnosis of a wide variety of central nervous system (CNS) diseases, including genetic and autoimmune diseases, infections, and malignant neoplasms. With rising number of chronic disorders such as viral hepatitis B, viral hepatitis C, and other sexually-transmitted infections, the role of PCR is increasing, which, in turn, benefits the molecular grade plates market.

Molecular grade plates are used in a variety of applications, such as Real Time PCR, both qualitative and quantitative, nucleic acid purification, and DNA sequencing. These plates are built for common uses such as sample storage and other high throughput applications.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/32283

Companies covered in Molecular Grade Plates Market Report

  • Thermo fisher scientific
  • Merck KGA
  • Bio-Rad
  • Takara Bio, Inc.
  • QIAGEN N.V.
  • Pall Corporation
  • Eppendorf Corporate
  • Tarsons
  • Applied Biological Materials Inc.
  • Greiner AG
  • Brooks Life Sciences
  • Corning Incorporated
  • Cytiva

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/32283

The COVID-19 pandemic has positively impacted the global molecular grade plates market. PCR tests have been found effective in diagnosing COVID-19. Currently, these tests are for people at risk of developing severe COVID-19. However, the pandemic has created a vast opportunity for the molecular biology industry to grow, and this is also leading to increased adoption of diagnostic products and consumables.

Key Takeaways from Molecular Grade Plates Market Study   

  • Holding over 60% market share, the PCR plates segment will experience the maximum positive impact during the COVID-19 pandemic, due to the rising adoption as a COVID19 diagnostic test.
  • Biotechnology companies are expected to hold more than half of the revenue share in the molecular grade plates market during the forecast period.
  • North America is the most lucrative regional market, owing to technological advancements coupled with rising research & development activities in the region.
  • With high demand for PCR testing, the COVID-19 pandemic is having a positive impact on the growth of the global molecular grade plates market.

“Growing manufacturers’ focus on developing new technologies in molecular biology applications, along with increasing funding in life science research are expected to propel growth of the global molecular grade plates market over the coming years,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32283

Increasing Life Science Research Activities Coupled with Innovative Business Strategies by Market Leaders Likely to Drive Market Growth

Increased adoption of new technologies in life science research, such as virtual clinical trials, telemedicine, and artificial intelligence will change traditional medical research and improve diversity. There have been many challenges in research, but despite this, the life sciences industry is continuously investing in R&D. This will increase revenue generation from the biotech industry as well.

  • For instance, commercialization of gene and cell therapies in the future will change the entire medicine world.

Key players in the molecular grade plates market are focusing on acquisition and partnerships with small players and suppliers for expansion of market presence. Manufacturers are adopting this strategy to expand their footprint across regions. Moreover, they are also focusing on research & development activities for the application of molecular grade plates in various research applications

  • For instance, in May 2018, Greiner Bio-One North America, Inc. acquired 3D Cell Culture Technology, previously owned by Nano 3D Biosciences, Inc.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the molecular grade plates market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (PCR plates, deep well plates, and sample preparation filter plates), application (PCR, next-gen sequencing (NGS), and sample storage), and end user (biotechnology companies and research & academic institutes), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Biocompatible Materials Market To Rescind With A CAGR Of 9% Fri, 09 Apr 2021 13:39:57 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701549.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701549.html persistencemarketresearch persistencemarketresearch

Biocompatible materials can be used in dental, orthopaedic and cardiovascular implants, drug delivery, hearing aids, tissue engineering scaffolds, prosthesis, cosmetics, and other medical device, as they are easily mouldable, biodegradable, and cost-effective. Biocompatible polymers experience harmless decomposition, which accelerates the healing process in the body. Moreover, manufacturers are focusing on developing their biocompatible portfolios and expanding their application for various diseases such as orthopedic disease and cardiovascular disease.

High prevalence of orthopedic and cardiovascular disorders and technological advancements represent additional opportunities for manufacturers. Hence, increasing investments by companies for advanced product development that are non-toxic and non-immunogenic are also expected to create growth opportunities for the biocompatible materials market. Approval and commercialization of novel biocompatible materials are providing a huge opportunity in developing countries.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/32234

Companies covered in Biocompatible Materials Market Report

  • Dupont
  • Ensinger
  • Stratasys Ltd.
  • Covestro AG
  • Foster Corporation
  • Merck KGaA
  • BASF SE (Exxon Mobil Corporation)
  • Wacker Chemie AG
  • Celanese Corporation
  • Royal DSM
  • Evonik Industries AG
  • Shin-Etsu Chemical Co. Ltd.
  • Henkel AG & Co.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/32234

According to a latest report published by PersistenceMarketResearch, the global biocompatible materials market is anticipated to experience a CAGR of over 9% during the forecast period (2020 – 2030).

 Key Takeaways from Biocompatible Materials Market Study

  • The synthetic polymers segment, under material type, is expected to hold significant revenue share in the biocompatible materials market.
  • Surgical & medical instruments are the most attractive applications with the highest share, followed by biocompatible implants. These segments are expected to grow at a higher rate as compared to other applications.
  • In terms of regional growth, North America, Europe, and Asia Pacific are manufacturing hubs for biocompatible materials, and are anticipated to witness rapid growth in the global biocompatible materials market.
  • The COVID-19 outbreak has created hindrances for the growth of the biocompatible materials market, which will persist in the first half of 2021.

“Upsurge in demand for medical devices and biopharmaceutical products for treatment and diagnosis purposes will boost the global biocompatible materials market over the coming years,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32234

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the biocompatible materials market are strengthening their product portfolios by launching new products.

  • For instance, in June 2020, Ensinger launched Laser direct structuring (LDS): TECACOMP LCP LDS 1049426 black, based on a Liquid Crystal Polymer (LCP).

Various players in the biocompatible materials market are focusing on growth strategies such as expansion, collaborations, and agreement licences.

  • In September, 2018, DuPont escalated the manufacturing capacity of the Kinston, North Carolina unit, for elevated production of the bio-based, high-performance DuPont™ Sorona® polymer.
  • In May 2019, Stratasys partnered with Solvay for an authorized materials partner program. The partnership will leverage the deposition modelling process of Stratasys with FDM Technology™ in 3D printing applications.
  • In October 2020, Covestro acquired the Resins & Functional Materials business (RFM) segment from Royal DSM. The acquisition will strengthen the portfolio of sustainable coating resins.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the biocompatible materials market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2020, on the basis of material type (polymers, metal, ceramic, and composites), application (surgical & medical instruments, implants, drug delivery, and others), end user (medical device manufacturers, academic and research institutes, and biopharmaceutical & pharmaceutical companies), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Serum Free Media Market To Witness A Penurious CAGR Of 7.3% Fri, 09 Apr 2021 13:39:35 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701548.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701548.html persistencemarketresearch persistencemarketresearch

Serum-free media gives more consistent cell growth and helps eliminate possible errors by minimizing the percentage of uneven growth among cell cultures. Consistency in cell culture coupled with superior cell growth with increased productivity makes it easier to use serum-free media for cell culture growth in biopharmaceutical production, research, and development.

Increasing focus on biopharmaceuticals to treat chronic diseases is fuelling biopharmaceutical production. The contribution of biopharmaceuticals in the healthcare industry is rising due to superior efficacy as compared to conventional drugs. Downstream processes are often regarded as a bottleneck of the biopharmaceutical industry, but it is increasing the usage of serum-free media for cell culture growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/15373

Companies covered in Serum Free Media Market Report

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza
  • Corning Incorporated
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • PAN Biotech
  • MP Biomedicals, LLC
  • PromoCell GmbH

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/15373

Increasing number of personalized targeted products, rise of advanced manufacturing technologies, continuously improving manufacturing scalability, and alternative downstream processes are some of the key drivers of increasing biopharmaceutical production. Moreover, production of serum-free media is largely concentrated in North America, Europe, and some parts of Asia Pacific, whereas, it has limited availability in untapped biopharmaceutical markets such as the Middle East & Africa, Latin America, and some countries of Asia.

Thus, it has huge scope for manufacturing to improve availability and provide cost-effective products in Latin America and MEA.

According to a latest report published by PersistenceMarketResearch , the global serum-free media market is expected to witness a CAGR of more than 7% during the forecast period (2020 – 2030), to close in on a valuation of US$ 3 Bn by the end of 2030.

 Key Takeaways from Serum-Free Media Market Study

  • The CHO cell media segment under media type is expected to hold more than twenty percent of revenue share in the serum-free media market.
  • By end user, biopharmaceutical companies held the highest market share in 2019. Serum-free media is significantly used in drug development and cell culture, which is anticipated to drive demand over the coming years.
  • Countries such as the U.S., Germany, India, and China are expected to experience significant growth in the global serum-free media market over the coming years, due to increase in drug development activities in these regions.
  • The COVID-19 outbreak has had a negative impact on the global serum-free media market, as a result of lockdowns and closing of manufacturing facilities across regions.

“Rise in biopharmaceutical industries and demand for cell therapies for cancer treatment will boost the global serum-free media market,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15373

Collaboration & Acquisitions – Key Strategies amongst Market Players

Leading players in the serum-free media market are strengthening their product portfolios by launching new products.

  • For instance, in March 2016, Lonza launched PowerCHO Advance™ Media for improved protein-production yields.

Various players in the serum-free media market are focusing on growth strategies such as collaborations and agreement licences.

  • In June 2018, Fujifilm completed the acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media.
  • In December 2019, Sartorius announced the acquisition of a majority stake in cell culture media specialist Biological Industries.
  • In May 2017, Lonza acquired cell and gene contract manufacturer PharmaCell.
  • In April 2017, Thermo Fisher Scientific completed the acquisition of Brammer Bio, a viral vector manufacturer for gene and cell therapies.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on serum-free media in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of media type (protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media, immunology media, CHO cell media, and chemically-defined media), animal source (camelids and sharks), and end user (biopharmaceutical companies, clinical research organizations, and academic research centers), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Volumetric Pumps Market To Mark Robustness In The Form Of A Robust CAGR ~4.8% Fri, 09 Apr 2021 13:39:12 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701547.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701547.html persistencemarketresearch persistencemarketresearch

Increasing prevalence of cancer and other chronic disorders, and rise in number surgical procedures across the globe, are expected to surge demand for volumetric pumps. Additionally, presence of a well-structured regulatory framework for using volumetric pumps in regions such as North America and Europe has been playing an important role in shaping the prospects of the global volumetric pumps market.

The COVID-19 pandemic is having a significant positive impact on the volumetric pumps market, as a result of shortage of infusion pumps to treat patients using nebulization support with rising incidence of dosing-errors cases. To overcome dosing-errors and inaccuracy in delivering drugs, surge in demand for volumetric pumps is being witnessed.

Want Insights To Volumetric Pumps Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/32174

Companies covered in Volumetric Pumps Market Report

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Terumo Corporation
  • ICU Medical, Inc.
  • Becton, Dickinson and Company
  • Smiths Medical
  • Woodley Equipment Company Ltd.
  • Mindray Medical International Ltd.
  • ADOX S.A
  • Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd.
  • Guangzhou Huaxi Medical Science Technology Co. Ltd.
  • ASCOR
  • Shenzhen Shenke Medical Instrument Technical Development Co. Ltd.
  • Daiwaha corp. ltd.
  • CONTEC MEDICAL SYSTEMS Co. Ltd.

Planning To Conclude Your Strategy On A Decisive Note In The Volumetric Pumps Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/32174 

The global volumetric pumps market is estimated to expand at a CAGR of more than 5% over the forecast period (2020-2030)

Key Takeaways from Volumetric Pumps Marker Study

  • Based on product type, peristaltic pumps dominated the volumetric pumps market, owing to their advantage of lowering dose-error and delivering drugs with accurate flow rates using the peristalsis mechanism.
  • The chemotherapy/ oncology segment is expected to obtain maximum revenue share over the forecast period, due to rising incidence of cancer and the treatment given in continuous cycles.
  • Among all end users, the hospitals segment hold a high market revenue share, due to the availability of advanced facilities and experienced professionals across hospitals around the world.
  • The COVID-19 pandemic crisis is having a positive effect on the demand for volumetric pumps across the world.

 “Rising incidence of dosing-error cases and inaccuracy in drug delivery are expected to shift preferences toward advanced volumetric pumps, which will propel the growth of the global volumetric pumps market over the coming years,” says a PMR analyst.

How About Knowing The Product/Technology Driving The Volumetric Pumps Market Before Investing Therein? Click The “Purchase Now” Button Of Our Volumetric Pumps Market Report! https://www.persistencemarketresearch.com/checkout/32174    

Volumetric Pumps Market: Key Strategies amongst Players

Worldwide, leading key players in the volumetric pumps market are extensively focusing on technological advancements, acquisition, and collaborations to expand their product portfolios. These key strategies are expected to propel the growth of the volumetric pumps market too. Players dealing in hospital supplies are increasingly targeting the volumetric pumps market for acquiring leading companies or those ones facing a large number of product recalls.

  • For instance, in February 2015, Pfizer acquired Hospira, as the latter had been facing one of the highest product recalls in the industry, which was then acquired by ICU Medical in 2017.
  • Additionally, Carefusion was acquired by Becton Dickinson, as the latter wanted to expand its market share in the surgical supplies segment.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the volumetric pumps market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The market has been segmented on the basis of product type (peristaltic and cassette/ piston), application (chemotherapy/ oncology, pediatrics/ neonatology, analgesia, and hematology), and end user (hospitals, ambulatory surgical centers, clinics, and others), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Triple Negative Breast Cancer Treatment Market To Embark Upon A Double Digit CAGR 4.7% Fri, 09 Apr 2021 13:38:50 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701546.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701546.html persistencemarketresearch persistencemarketresearch

Significant rise in awareness about preventative therapies is anticipated to drive the triple-negative breast cancer treatment market during the forecast period. According to WHO, the risk of developing cancer before the age of 75 years is around 20.2% and that of dying from cancer before the age of 75 years is around 10.6%. According to the American Cancer Society, in 2019, around 268,600 new cases of invasive breast cancer were diagnosed among women and approximately 2,670 cases were diagnosed in men. Thus, rising prevalence of breast cancer among the population is expected to propel the growth of the triple-negative breast cancer treatment market over the coming years.

Get Going With Sample Of Triple-Negative Breast Cancer Treatment Market Report! https://www.persistencemarketresearch.co/samples/14305 

Companies covered in Triple Negative Breast Cancer Treatment Market Report

  • AstraZeneca plc.
  • Pfizer, Inc.
  • F. Hoffman – La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Mylan N.V.
  • Eli Lilly and Company
  • Celgene Corporation
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.

How About Re-Inventing The Methodical Wheel In The Triple-Negative Breast Cancer Treatment Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/14305

Persistence Market Research predicts that the global triple-negative breast cancer treatment market will exhibit a CAGR of around 5% over the forecast period (2020-2030).

Key Takeaways from Triple-Negative Breast Cancer Treatment Market Study    

  • Based on drug, paclitaxel is expected to gain traction in the global triple-negative breast cancer treatment market during the forecast period, owing to its efficacy.
  • The hospital pharmacies segment is expected to be the most attractive segment in the global triple-negative breast cancer treatment market by distribution channel, and will hold the highest market share.
  • North America will dominate the global triple-negative breast cancer treatment market by region over the forecast period, owing to growing population, rising prevalence of breast cancer, and excessive consumption of tobacco and alcohol.
  • The triple-negative breast cancer treatment market is expected to experience a short-term negative impact during the COVID-19 pandemic crisis, owing to labor shortage, transportation restrictions, supply chains issues, and shortage of medical instruments for cancer.

Rising prevalence of breast cancer, increased focus on innovation of robust drug pipeline and combination therapies, developments in therapeutic areas, and growing concerns about maintaining environmental hygiene after the COVID-19 outbreak are factors expected to contribute to the growth of the global triple-negative breast cancer treatment market,” says a PMR analyst.

Keeping A Tab On Key Players In The Triple-Negative Breast Cancer Treatment Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Triple-Negative Breast Cancer Treatment Market Report! https://www.persistencemarketresearch.com/checkout/14305

Accelerated Expansion and Acquisitions & Collaborations by Leading Industry Players to Meet Unmet Demand

Leading manufacturers in the global triple-negative breast cancer treatment market are extensively focusing on expansion of their manufacturing. Government initiatives such as awareness programs, investments by regional manufacturers, and increasing healthcare expenditure are some of the key trends expected to drive the triple-negative breast cancer treatment market over the coming years.

  • For instance, in April 2018, Servier acquired Shire’s oncology business to gain direct commercial access in the U.S. At present, Servier offers Oncaspar in the U.S. Prior to this, Shire and Baxalta were involved in a US$ 32 billion merger in 2016.
  • Additionally, in January 2018, Sanofi announced its plan to acquire ELOCTATE.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the triple-negative breast cancer treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of drug (doxorubicin, cyclophosphamide, paclitaxel, docetaxel, carboplatin/cisplatin, and others) and distribution channel (hospitals, cancer research institutes, and retail clinics), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Single-Domain Antibody Platforms Market To Witness A Growth Of 10%, To Reach Fri, 09 Apr 2021 13:38:28 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701545.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701545.html persistencemarketresearch persistencemarketresearch

Monoclonal antibodies are highly efficient as therapeutics against viral infections, immune diseases, and cancer. However, they are large in size and unable to access some epitopes, besides the production cost being high. Hence, single-domain antibodies (sdAbs) is an alternative for monoclonal due to larger number of accessible epitopes, smaller size, relatively low production costs, and potent inhibitors against immune and viral diseases. Currently, single-domain antibodies are being developed against a number of viruses, including influenza viruses, HIV, hepatitis C virus (HCV), enteric viruses, and respiratory syncytial virus (RSV).

Technological advancements in single-domain antibody platforms such as production of bispecific and multi-specific antibodies to target particular antigens during therapeutic developments are some other factors that will boost the growth of the single-domain antibody platforms market.

Planning Forward? Access Sample Of Single-Domain Antibody Platforms Market Report! https://www.persistencemarketresearch.co/samples/28351

Companies covered in Single Domain Antibody Platforms Market Report

  • Creative BioLabs A
  • Synbio Technologies
  • ProSci Incorporated
  • BioCat GmbH
  • Antibody Design Labs
  • GenScript
  • Oak BioSciences, Inc.
  • Rockland Immunochemicals, Inc
  • Hybrigenics Services
  • NeoClone Biotechnology International LLC
  • Kaneka Eurogentec S.A
  • ProteoGenix

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Single-Domain Antibody Platforms Market? https://www.persistencemarketresearch.co/methodology/28351

According to a latest report published by PMR, the global single-domain antibody platforms market is projected to be valued at US$ 22 Mn in 2020, and is expected to witness an impressive CAGR of around 10% during the forecast period (2020 – 2030).

 Key Takeaways from Single-Domain Antibody Platforms Market Study     

  • The bispecific single-domain antibody segment under platform type is expected to contribute more than 30% of revenue share in the single-domain antibody platforms market.
  • By application, therapeutic development accounted for the highest market share in 2019. Single-domain antibodies are highly effective in immune therapy, and antiviral therapy is anticipated to drive demand for single-domain antibody platforms.
  • Developing countries such as India, China, and South Africa are projected to register positive growth over the coming years, due to increase in drug development activities in these regions.
  • Leading players are focused on improving their service and established collaborations with research institutes and provide customized products.
  • The COVID-19 outbreak has created a positive impact on the single-domain antibody platforms market, with increased demand for antibodies in the treatment against COVID-19.

“Rise in prevalence of infectious disease and demand for immunotherapy for preventive treatments will boost the global single-domain antibody platforms market,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Single-Domain Antibody Platforms Market? Go To “Purchase Now” To Have Our Single-Domain Antibody Platforms Market Report! https://www.persistencemarketresearch.com/checkout/28351

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the single-domain antibody platforms market are strengthening their product portfolios by launching new products.

  • For instance, in July 2020, Creative Biolabs developed over 400 types of therapeutic antibodies that can be applied to the study on COVID-19 drugs.
  • ProSci Incorporated announced the release of multiple single-domain antibodies against the human programmed death ligand 1 (PD-L1).
  • In May, 2016, Antibody Design Labs offered a complete line of services for single-domain antibody development, including single-domain antibody phage libraries, immunization, and large-scale production of recombinant single-domain antibodies

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the single-domain antibody platforms market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of platform type (multi-specific single-domain antibody, bispecific single-domain antibody, multivalent single-domain antibody, and mono-specific single-domain antibody), animal source (camelids and sharks), application (diagnostic laboratories, therapeutic development, and research & development activities) and end user (diagnostic laboratories, clinical laboratories, academic and research institutes, and pharmaceutical and biotechnology companies), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Antibiotic Resistance Market To Quell Covid-19; To Reach US$ 12.6 Bn Thu, 08 Apr 2021 07:16:59 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701048.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701048.html persistencemarketresearch persistencemarketresearch

Antibiotic resistance is one of the biggest public health concerns today. In the U.S., over 2 million people suffer from an antibiotic-resistant infection annually. Growing mortality rate due to these infections has generated a gateway for pharmaceutical manufacturers to develop novel antibiotics. Fighting this threat is a national and public health priority that needs a collaborative approach among healthcare providers and governments. Human overuse of antibiotics leads to the development of antibiotic resistance, which, in turn, demands newer antibiotics.

Escherichia coli and Klebsiella pneumonia are highly resistant to the class of antibiotics called Carbapenem. Carbapenem-resistant Enterobacteriaceae (CRE) infection is a dangerous condition, because these microbes can cause infections in almost all parts of the body. Some of the very severe and common infections include urinary tract infections, ventilator-associated pneumonia bloodstream infections, and intra-abdominal abscesses. These infections are more dangerous as they are resistant to Carbapenem antibiotic drugs, which are considered to be the last resort of defence to treat multidrug-resistant bacterial infections.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27895

Companies covered in Antibiotic Resistance Market Report

  • Pfizer Inc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Johnsons & Johnson
  • Baxter Healthcare Corporation
  • Zydus Cadila
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Dr. Reddy’s Laboratories Ltd.
  • Mayne Pharma Group Limited.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Shanghai Pharmaceutical Group Co., Ltd.
  • Yuhan Corporation
  • Abbott Laboratories

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/27895

Among all the regions, Asia Pacific countries are regarded as high CRE-prevalent regions, where the rate of CRE detection has been continuously increasing.

According to a latest report published by Persistence Market Research, the global antibiotic resistance market is projected to be valued at US$ 12.6 Bn by the end of 2031, witnessing a steady CAGR of over 4% during the forecast period (2021 – 2031).

Key Takeaways from Antibiotic Resistance Market Study        

  • Beta lactam antibiotics are expected to contribute more than 25% of the revenue share to the market by 2031. These antibiotics target a broad range of microbes, leading to their higher adoption.
  • By distribution channel, hospitals pharmacies will lead by acquiring more than half of the market share. Most antibiotic-resistant infections are hospital-acquired, and hence, hospitals are major treatment providers.
  • By indication, complicated urinary tract infections (CUTIs) are expected to dominate the market, owning to their higher prevalence, especially in the female population. These infections are common in developing regions with poor hygiene practices.
  • North America represents the largest regional market for antibiotic resistance, with one-fourth global market share.
  • Key players are focused on strengthening their clinical pipelines with new discoveries of antibiotics and combination therapies.
  • The COVID-19 outbreak moderately affected the market. Demand for antibiotics during lockdowns was low as the sole focus was attending COVID-19 patients.
  • Demand for antibiotics in Asia Pacific countries, especially India and China, is unmatched. Antibiotic usage in overwhelming in these countries, leading to increased rates of antibiotic resistance, expected to expand at CAGRs above 5% through 2031.
  • The U.S. market holds a major share accounting more than 90% of the total North America market.

“Emergence of multi-drug-resistant bacteria due to excess consumption of antibiotics is anticipated to accelerate antibiotic resistance market growth,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/27895

Strategic Partnerships and Funding by Key Players Aiding Market Expansion

Prominent leaders in the antibiotics industry have pledged to fund a significant amount to bolster the research & development of new antibiotics.

  • For instance, Pfizer has assured to invest US$ 100 Mn in R&D of novel antibiotic discovery. This investment will go into its Antimicrobial Resistance (AMR) Action Fund.
  • Novartis partnered with over 20 prominent pharmaceutical companies to tackle antibiotic resistance by contributing to the Antimicrobial Resistance (AMR) Action Fund.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the antibiotic resistance market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, on the basis of drug class (beta lactam antibiotic, cephalosporin, quinolones antibiotics, macrolide antibiotics, tetracycline, oxazolidinones and others), by pathogen, (staphylococcus aureus, streptococcus pneumonia, neisseria gonorrhoeae, enterococcus faecium, escherichia coli, klebsiella pneumonia, shigella, clostridium difficile, and others), disease (community acquired bacterial pneumonia (CABP), hospital acquired bacterial pneumonia/ ventilator (HABP/VABP), complicated urinary tract infections (CUTI), complicated intra-abdominal infections (CIAI), blood stream infections (BSI), abdominal infection and diarrhoea [clostridium difficile infections (CDI) & shigella], acute bacterial skin and skin structure infections (ABSSSI), and drug resistant gonorrhoeae), mechanism of action (Cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors and others), and distribution channel (hospitals pharmacies, retail pharmacies, and online pharmacies), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Single Use Bioprocess System Market To Settle At US$ 4.4 Bn Thu, 08 Apr 2021 07:16:37 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701047.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701047.html persistencemarketresearch persistencemarketresearch

Growing demand for single-use bioprocess systems due to their advantages of lesser cross-contamination chances provides a strong foothold for their use in the biopharmaceutical industry. Pharmaceutical and biotechnology companies are looking forward to continuous manufacturing of pharma products with optimizing speed and sterility assurance, which is expected to surge demand for single-use bioprocess systems. Use of disposable products for bioprocessing application enhances upstream and downstream processes with better safety, sterility, and reliability. Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Increasing investments toward manufacturing plant expansion and rising emphasis on low-cost disposable bioprocess product development by key market players are other major factors expected to aid market growth. The global single-use bioprocess systems market was valued at US$ 4.4 Bn in 2020, and is expected to exhibit a CAGR of close to 20% over the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12142

Companies covered in Single Use Bioprocess System Market Report

  • Thermo Fisher Scientific Inc.
  • Sartorius Stedim Biotech
  • Danaher Corporation
  • Merck Millipore
  • Eppendorf AG
  • Celltainer Biotech B.V.
  • Applikon Biotechnology
  • Cellexus Ltd.
  • Parker Hannifin Corp
  • Mettler-Toledo International, Inc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12142

Key Takeaways from Single-use Bioprocess Systems Market Study

  • The bioreactor segment by component held maximum value, owing to growing use of single-use bioreactors for cell culture and fermentation processes.
  • By application, GMP and commercial production captured a notable revenue share of more than 71%.
  • Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
  • North America is a most lucrative market with a revenue of around 34% in 2020; however, it will lose some of its market share over the next ten years.
  • Growing healthcare expenditure and increasing demand for low-cost biologics in Asian countries are expected to propel market growth in the region to more than one-third of the global share by 2030.
  • The markets in Russia, China, and Spain are anticipated to expand at CAGRs of 16%, 18.4%, and 17%, respectively, through 2030.

“Growing demand for disposable bioprocess systems to improve the manufacturing speed and efficacy of biologics at low cost is expected to flourish market growth and provide a competitive advantage to players,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12142

Expansion of Manufacturing Capacity – Imperative Strategy for Market Players

Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand. Leading companies are also opening new product distribution facilities across regions.

For instance, in June 2017, Parker Hannifin opened a new parker bioscience filtration division in Birtley, the U.K., and Oxnard, California, in the U.S., to deliver international bioprocessing, food and beverage, and healthcare solutions.

What else is in the report?

Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020–2030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Commercial Aquaculture Vaccines Market To Bank On Its Armory Of Product/Service Offerings By Reaching Expand Twofold Thu, 08 Apr 2021 07:16:14 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701046.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701046.html persistencemarketresearch persistencemarketresearch

Increasing risk of transmission of pathogens from animal food is expected surge demand for commercial aquaculture vaccines. According to the Food and Agriculture Organization (FAO) of the United Nations 2020, aquaculture accounted for around 46 percent of total food production and 52 percent of fish for human consumption. Besides, aquatic species farming is one of the fastest-growing food sectors, globally. Commercial aquaculture vaccines are projected to gain traction due to shift of the aquaculture industry toward preventive vaccinations from conventional antibiotic treatments, due to increased risk of dissemination. According to the Global Aquaculture Alliance, Chilean salmon farmers have cut antibiotic usage substantially over the last three years.

An increase in global consumption and production of aquatic species exhibits exponential growth potential for the commercial aquaculture vaccines market. Additionally, increased prevalence of bacterial and zoonotic infections among aquaculture species has been observed, which has widened market opportunities.

The COVID-19 pandemic has changed animal healthcare priorities and spending, but this is considered to be a short-term negative impact on the vaccines market. Disruptions in supply chain across the global fish aquaculture industry and rising awareness of animal to human pathogen transmission risks are expected to slow down the market in the short term.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32289

Companies covered in Commercial Aquaculture Vaccines Market Report

  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Canada inc
  • HIPRA
  • Elanco
  • AQUATRECK ANIMAL HEALTH S.L.
  • MSD Animal Health
  • Zoetis LLC
  • Centrovet Laboratories inc.
  • Intervet-International BV

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32289

Overall, the global commercial aquaculture vaccines market is projected to expand at a healthy CAGR of close to 7% through 2030.

Key Takeaways from Commercial Aquaculture Vaccines Market Study

  • Based on vaccine type, inactivated vaccines are the most profitable segment leading the market, and are expected to gain more than 70% of market revenue share over the forecast period.
  • Among all the pathogens, bacteria widely dominates (over 70%) due to high prevalence of bacterial infections among aquaculture.
  • Salmon is a widely dominating species in the market, due to rising production of the fish in leading developed countries, accounting for more than 55% of market share value.
  • The intraperitoneal route of administration is most preferred, due to high immune response elicitation of fish, and low stress and post-vaccination side effects.
  • Among the different end-users, fish farming companies will hold more than 80% of revenue share over the forecast period.
  • Europe is the largest market for commercial aquaculture vaccines, with Norway holding close to half of the share in this regional market.
  • Growth of the market is pegged at just 2.2% in 2021, but over the long term through 2030, it will get back to its normal growth trajectory of close to 7% CAGR.

“Increasing awareness of animal food pathogen transmission risks and rising prevalence of zoonotic infections are expected to boost demand for commercial aquaculture vaccines market,” says an analyst of Persistence Market Research

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32289

Trends in Commercial Aquaculture Vaccines Market

The manual vaccination process led to various adverse effects with high costs, owing to the lack of highly skilled and large number workforce needed, significant handling stress, and risk of post-vaccination infections. Thus, increased shift toward automated vaccination technology is expected to boost the commercial aquaculture vaccines market growth. For instance, Aqualife developed an automated Incubot 2, a mobile platform that would offer automated vaccination to smaller fish farms.

Rising demand for insurance in matured markets is an upcoming trend. Favourable insurance policies is an emerging trend to sustain the commercial aquaculture vaccines market across the globe. Introduction of third-party payers has supported the aquaculture sector globally, leading to a build-up of new sales channels for aquaculture vaccines.

For instance, according to the Food and Agriculture Organization of U. N., around 83 percent of fishers purchase insurance coverage for fish aquaculture farming.

Expansion of Manufacturing Capabilities & New Product Launches – Key Strategies for Market Players

Key players in the commercial aquaculture vaccines market are focussing on expanding their manufacturing capabilities to meet the unmet demand of commercial aquaculture vaccines. Given the consolidation in the market, top players are focusing on acquisitions at regional levels. The trend is being observed across various emerging regions.

  • For instance, in June 2020, Elanco received European Commission approval for the acquisition of Bayer Animal Health (US $ 5.17 Bn deal), and become the world’s second-largest animal health company. The combined business is expected to strengthen and accelerate the company’s innovation, portfolio, and product strategy.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the commercial aquaculture vaccines market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, based on vaccine type, (DNA, subunit, attenuated, and inactivate), pathogen (bacteria and virus), species (carp, turbot, salmon, tilapia, trout, sea bass, bream, and others), based on route of administration (intramuscular, intraperitoneal, immersion, and oral), and end user (fish farming companies, fish veterinary clinics, and aquatic research institute), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Oral Hygiene Products Market To Get On To The Magnanimous Mode At US$ 4,830 Million Thu, 08 Apr 2021 07:15:52 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701045.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701045.html persistencemarketresearch persistencemarketresearch

Oral hygiene products are used to treat dental plaque/biofilms, dental caries, gingivitis, halitosis, periodontitis and peri-implantitis. Increasing prevalence of these conditions across the world is expected to boost demand in the global oral hygiene products market. For instance, according to the Global Burden of Disease (GBD), severe periodontitis is the 6th-most prevalent oral disease occurring worldwide, and accounts for 11.2% prevalence rate.

Several initiatives for oral health awareness are being undertaken by leading oral hygiene market players. Major companies such as Colgate-Palmolive, Johnson & Johnson, Unilever, and Proctor & Gamble are focused on spreading awareness regarding good oral health and dental hygiene. For instance, the Indian Dental Association (IDA) drafted the National Oral Health Programme to address the burden of dental disease effectively for bringing about ‘optimal oral health’ for all by 2020.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/25915

Companies covered in Oral Hygiene Products Market Report

  • Colgate-Palmolive
  • Procter & Gamble
  • Unilever
  • GlaxoSmithKline
  • Johnson & Johnson
  • 3M Company
  • Dabur India Ltd.
  • Dentsply International Inc.
  • Ultradent Products, Inc.
  • Dentaid SL

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/25915

According to the latest report published by PersistenceMarketResearch, the global oral hygiene products market is anticipated to experience a steady CAGR of over 4% during the forecast period (2020–2030).

Key Takeaways from Oral Hygiene Products Market Study    

  • The toothpaste segment, under product, is expected to hold more than one-third revenue share in the global oral hygiene products market.
  • Dental plaque/biofilms and dental caries are leading indications and account for around 60% dental problems, followed by gingivitis. These segments are expected to grow at a higher rate as compared to other indications.
  • In terms of regional growth, East Asia and South Asia together hold more than 35% of the global oral hygiene products market value share. North America is a lucrative region with higher product adoption as compared to other regions.
  • The COVID-19 outbreak has created hindrances for the growth of the oral hygiene products market as most non-essential medical procedures are being postponed; this situation will persist in the first half of 2021 as well.

“Rising awareness regarding essential oral care and increase in prevalence of dental disorders will boost the global oral hygiene products market over the coming years. Wide distribution channel of oral hygiene products makes it more lucrative for expansion in the coming decade, where supermarkets/hypermarkets will be the largest contributor. Low capital cost required for manufacturing oral hygiene products will result in increasing number of market players in future,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/25915

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the oral hygiene products market are strengthening their product portfolios by launching new products.

  • Procter & Gamble launched new products in oral care such as Gum DetoxifyTM Toothpaste by Crest®, which is formulated for significantly improved gum health.

Various players in the oral hygiene products market are focusing on growth strategies such as expansion, collaborations, and agreement licences.

  • In Jan 2018, 3M and 3Shape announced a collaboration to advance the field of orthodontics via digital workflows, which intends to support indirect bonding, clear aligners, and other emerging digital orthodontic workflows.
  • In June 2016, Dentsply International Inc. announced the acquisition of MIS Implants Technologies Ltd., a manufacturer of dental implants.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the oral hygiene products market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, based on product (toothpaste, toothbrush, mouth wash/ rinse, floss, teeth whitening, orthodontic wax, and denture cleansers & fixatives), indication (dental plaque/biofilms, dental caries, gingivitis, halitosis, periodontitis, and peri-implantitis), and distribution channel (hospital pharmacies, supermarkets/ hypermarkets, drug stores, retail pharmacies, and e-Commerce), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Molecular Grade Plates Market To Be In Conjunction With Growth At Expand Twofold Thu, 08 Apr 2021 07:15:30 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701044.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701044.html persistencemarketresearch persistencemarketresearch

Chronic diseases such as cancer, viral infections, and cardio vascular disorders are constantly increasing across the world. Polymerase chain reaction (PCR) is a broadly-used test for the diagnosis of a wide variety of central nervous system (CNS) diseases, including genetic and autoimmune diseases, infections, and malignant neoplasms. With rising number of chronic disorders such as viral hepatitis B, viral hepatitis C, and other sexually-transmitted infections, the role of PCR is increasing, which, in turn, benefits the molecular grade plates market.

Molecular grade plates are used in a variety of applications, such as Real Time PCR, both qualitative and quantitative, nucleic acid purification, and DNA sequencing. These plates are built for common uses such as sample storage and other high throughput applications.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/32283

Companies covered in Molecular Grade Plates Market Report

  • Thermo fisher scientific
  • Merck KGA
  • Bio-Rad
  • Takara Bio, Inc.
  • QIAGEN N.V.
  • Pall Corporation
  • Eppendorf Corporate
  • Tarsons
  • Applied Biological Materials Inc.
  • Greiner AG
  • Brooks Life Sciences
  • Corning Incorporated
  • Cytiva

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/32283

The COVID-19 pandemic has positively impacted the global molecular grade plates market. PCR tests have been found effective in diagnosing COVID-19. Currently, these tests are for people at risk of developing severe COVID-19. However, the pandemic has created a vast opportunity for the molecular biology industry to grow, and this is also leading to increased adoption of diagnostic products and consumables.

Key Takeaways from Molecular Grade Plates Market Study   

  • Holding over 60% market share, the PCR plates segment will experience the maximum positive impact during the COVID-19 pandemic, due to the rising adoption as a COVID19 diagnostic test.
  • Biotechnology companies are expected to hold more than half of the revenue share in the molecular grade plates market during the forecast period.
  • North America is the most lucrative regional market, owing to technological advancements coupled with rising research & development activities in the region.
  • With high demand for PCR testing, the COVID-19 pandemic is having a positive impact on the growth of the global molecular grade plates market.

“Growing manufacturers’ focus on developing new technologies in molecular biology applications, along with increasing funding in life science research are expected to propel growth of the global molecular grade plates market over the coming years,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32283

Increasing Life Science Research Activities Coupled with Innovative Business Strategies by Market Leaders Likely to Drive Market Growth

Increased adoption of new technologies in life science research, such as virtual clinical trials, telemedicine, and artificial intelligence will change traditional medical research and improve diversity. There have been many challenges in research, but despite this, the life sciences industry is continuously investing in R&D. This will increase revenue generation from the biotech industry as well.

  • For instance, commercialization of gene and cell therapies in the future will change the entire medicine world.

Key players in the molecular grade plates market are focusing on acquisition and partnerships with small players and suppliers for expansion of market presence. Manufacturers are adopting this strategy to expand their footprint across regions. Moreover, they are also focusing on research & development activities for the application of molecular grade plates in various research applications

  • For instance, in May 2018, Greiner Bio-One North America, Inc. acquired 3D Cell Culture Technology, previously owned by Nano 3D Biosciences, Inc.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the molecular grade plates market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (PCR plates, deep well plates, and sample preparation filter plates), application (PCR, next-gen sequencing (NGS), and sample storage), and end user (biotechnology companies and research & academic institutes), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Intubation Market To Move Away From Stagnation, Reach US$ 1.3 Bn Thu, 08 Apr 2021 07:15:07 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701043.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701043.html persistencemarketresearch persistencemarketresearch Rising number of surgical conditions due to trauma and chronic diseases such as diabetes, chronic respiratory, neurological, and renal diseases are expected to increase demand of medical intubation procedures, and subsequent use of intubation medical devices. For instance, increase in number of surgical procedures will have a direct impact on the sale of intubation products. According to a WHO study, in 2010, around 321.5 million surgical procedures were carried out to address the burden of different diseases for a global population of 6.9 billion.

Moreover, rising global adoption of intubation-based surgical procedures, extensive clinical research, and increasing launches of highly sophisticated intubation medical devices are responsible for the growth of the intubation market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/15676

Companies covered in Intubation Market Report

  • Medtronic
  • Deas S.R.L
  • Medis Medical
  • Smiths Medical
  • Flexicare Medical Limited

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/15676

Persistence Market Research predicts that the global intubation market will exhibit a 5% CAGR during the forecast period (2020-2030).

Key Takeaways from Intubation Market Study     

  • By product, the endotracheal tubes segment is expected to dominate the global intubation market during the forecast period, owing to high volume of surgical procedures that adopt the endotracheal intubation technique.
  • In terms of usage, the disposable intubation segment is expected to gain more than 3/4 of the intubation market share. Preference for disposable intubation medical devices is due to lower infection risk and convenience during intubation procedures.
  • Under the end user segmentation, hospitals and ambulatory surgical centres are expected to collectively gain more than 3/4 of the market by 2030.
  • North America is the highest revenue generating market by region, due to the launch of new products with rising adoption of intubation in surgical procedures, and an increasing elderly population. North America is expected to be followed by Europe in the global intubation market.
  • Lack of skilful workforce to perform intubation procedures and poorly developed healthcare infrastructures in developing economies are major challenges for the growth of the intubation market in these regions.
  • The COVID-19 pandemic will have a short-term negative impact on the global intubation market, owing to supply chain disruptions, reduced hospital-based procedures, and hampered research & development activities by companies in the intubation market. Due to the outbreak, many companies are focusing on finding a possible treatment option for COVID-19. Manufacturing industries around the world have been hampered due to global restrictions, causing unusual technology and business model disruption.

“Rising burden of surgical procedures and technological advancements are expected to drive the growth of the global intubation market,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15676

Disposable Intubation Products Dominate Market

Use of disposable medical devices in intubation and surgical procedures is increasing rapidly. Risk of infection with reused intubation devices and high cost associated with sterilization for reused products are projected to drive higher preference for disposable intubation devices. In addition, use of highly advanced biodegradable material for the manufacturing of intubation devices that facilitate the disposal of single-use intubation devices is pushing the trend of disposable intubation devices in the market.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the intubation market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product (airway management tubes and intubation accessories), usage (reusable and disposable), and end user (hospitals, ambulatory surgical centres, clinics, and research & diagnostic labs), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Autogenous Vaccine For Aquaculture Market To Witness An Extensive Growth With A CAGR Of 6% Wed, 07 Apr 2021 09:06:56 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700685.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700685.html persistencemarketresearch persistencemarketresearch

Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish species remains a global issue for fish farmers.

Autogenous vaccines have been playing a vital role in bacterial disease control in aquaculture. This is the most effective method for preventing a wide range of bacterial and viral diseases. Autogenous vaccines are widely accepted by aquaculture farming companies during emergency outbreaks, due to very few commercial vaccines being available for specific aquaculture-related diseases.

According to the latest report published by Persistence Market Research, the global autogenous vaccine for aquaculture market was valued at US$ 11 Mn in 2020, and is expected to witness a CAGR of 5.5% during the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32293

Companies covered in Autogenous Vaccine For Aquaculture Market Report

  • IDT Biologika GmbH (Ridgeway Biologicals Ltd)
  • MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
  • Ceva Biovac
  • Zoetis (PHARMAQAS)
  • Vaxxinova
  • Barramundi Asia Pte Ltd.(UVAXX Asia)
  • HIPRA
  • AniCon Labor GmbH
  • sanphar (ipeve)
  • Kennebec River Biosciences

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32293

 Key Takeaways from Autogenous Vaccine for Aquaculture Market Study

  • The salmon fish species is expected to contribute more than 40% revenue share to the market.
  • By pathogen type, bacteria held the highest market share in 2019, due to bacterial infections being more frequent across fish farms.
  • North America and Europe collectively account for nearly one-third share in the global autogenous vaccine for aquaculture market.
  • Leading players are focused on improving their services, and have established collaborations with fish farming companies to provide customized products.
  • Fish farming companies are expected to hold a prominent share in the market, owing to high adoption of autogenous vaccine services at these facilities.
  • The COVID-19 outbreak has had a negative impact on the global autogenous vaccine for aquaculture market, mainly due to export restrictions.
  • This industry has expanded at around 4% over the last 5 years, but growth is projected to increase to around 5.5% CAGR through 2030.
  • The United States accounts for around 20% of global demand.
  • Norway holds more than one-third of the share in Europe, which is the largest regional market for autogenous vaccines for aquaculture.

“Rise in prevalence of infectious diseases and demand for autogenous vaccines for preventive treatment will boost sales of autogenous vaccines for aquaculture over the coming years,” says an analyst at Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32293

Collaborations & Acquisitions Key Strategy amongst Market Players

Leading players in the autogenous vaccine for aquaculture market are strengthening their product portfolios through acquisitions and expanding their regional presence.

  • For instance, in July 2019, Ceva Santé Animale announced the acquisition of IDT’s veterinary pharmaceutical and R&D activities.
  • In April 2018, Pharmaq announced the production of fish vaccines at a development center in Suzhou, China.
  • In November 2016, Ceva announced the acquisition of Hertape Saude Animale Ltda. and Inova Biotecnologia Saude Animale Ltda., two leading Brazilian veterinary biopharmaceutical companies.

Various players in the autogenous vaccine for aquaculture market are focusing on growth strategies such as collaboration and agreement licences.

  • In December 2020, HIPRA announced its collaboration with IBM to digitize the animal vaccination process.
  • In April 2019, MARINNOVAC collaborated with CZVACCINES S.A and established AQUATRECK ANIMAL HEALTH S.L, an aquaculture pharmaceutical company.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the autogenous vaccine for aquaculture market in its latest study, presenting historical demand assessment of 2015 - 2019 and projections for 2020 - 2020, on the basis of fish species (salmon, tilapia, bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpus), pathogen type (bacteria and virus), and end user (fish farming companies and aquatic research institutes), across seven key regions of the world.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>
The Single Use Bioprocess System Market To Rescind With A CAGR Of 14.7% Wed, 07 Apr 2021 09:06:33 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700684.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700684.html persistencemarketresearch persistencemarketresearch

Growing demand for single-use bioprocess systems due to their advantages of lesser cross-contamination chances provides a strong foothold for their use in the biopharmaceutical industry. Pharmaceutical and biotechnology companies are looking forward to continuous manufacturing of pharma products with optimizing speed and sterility assurance, which is expected to surge demand for single-use bioprocess systems. Use of disposable products for bioprocessing application enhances upstream and downstream processes with better safety, sterility, and reliability. Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Increasing investments toward manufacturing plant expansion and rising emphasis on low-cost disposable bioprocess product development by key market players are other major factors expected to aid market growth. The global single-use bioprocess systems market was valued at US$ 4.4 Bn in 2020, and is expected to exhibit a CAGR of close to 20% over the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12142

Companies covered in Single Use Bioprocess System Market Report

  • Thermo Fisher Scientific Inc.
  • Sartorius Stedim Biotech
  • Danaher Corporation
  • Merck Millipore
  • Eppendorf AG
  • Celltainer Biotech B.V.
  • Applikon Biotechnology
  • Cellexus Ltd.
  • Parker Hannifin Corp
  • Mettler-Toledo International, Inc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12142

Key Takeaways from Single-use Bioprocess Systems Market Study

  • The bioreactor segment by component held maximum value, owing to growing use of single-use bioreactors for cell culture and fermentation processes.
  • By application, GMP and commercial production captured a notable revenue share of more than 71%.
  • Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
  • North America is a most lucrative market with a revenue of around 34% in 2020; however, it will lose some of its market share over the next ten years.
  • Growing healthcare expenditure and increasing demand for low-cost biologics in Asian countries are expected to propel market growth in the region to more than one-third of the global share by 2030.
  • The markets in Russia, China, and Spain are anticipated to expand at CAGRs of 16%, 18.4%, and 17%, respectively, through 2030.

“Growing demand for disposable bioprocess systems to improve the manufacturing speed and efficacy of biologics at low cost is expected to flourish market growth and provide a competitive advantage to players,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12142

Expansion of Manufacturing Capacity – Imperative Strategy for Market Players

Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand. Leading companies are also opening new product distribution facilities across regions.

For instance, in June 2017, Parker Hannifin opened a new parker bioscience filtration division in Birtley, the U.K., and Oxnard, California, in the U.S., to deliver international bioprocessing, food and beverage, and healthcare solutions.

What else is in the report?

Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 - 2019 and projections for 2020–2030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>
The Commercial Aquaculture Vaccines Market To Witness A Penurious CAGR Of 6.7% Wed, 07 Apr 2021 09:06:11 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700683.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700683.html persistencemarketresearch persistencemarketresearch

Increasing risk of transmission of pathogens from animal food is expected surge demand for commercial aquaculture vaccines. According to the Food and Agriculture Organization (FAO) of the United Nations 2020, aquaculture accounted for around 46 percent of total food production and 52 percent of fish for human consumption. Besides, aquatic species farming is one of the fastest-growing food sectors, globally. Commercial aquaculture vaccines are projected to gain traction due to shift of the aquaculture industry toward preventive vaccinations from conventional antibiotic treatments, due to increased risk of dissemination. According to the Global Aquaculture Alliance, Chilean salmon farmers have cut antibiotic usage substantially over the last three years.

An increase in global consumption and production of aquatic species exhibits exponential growth potential for the commercial aquaculture vaccines market. Additionally, increased prevalence of bacterial and zoonotic infections among aquaculture species has been observed, which has widened market opportunities.

The COVID-19 pandemic has changed animal healthcare priorities and spending, but this is considered to be a short-term negative impact on the vaccines market. Disruptions in supply chain across the global fish aquaculture industry and rising awareness of animal to human pathogen transmission risks are expected to slow down the market in the short term.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32289

Companies covered in Commercial Aquaculture Vaccines Market Report

  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Canada inc
  • HIPRA
  • Elanco
  • AQUATRECK ANIMAL HEALTH S.L.
  • MSD Animal Health
  • Zoetis LLC
  • Centrovet Laboratories inc.
  • Intervet-International BV

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32289

Overall, the global commercial aquaculture vaccines market is projected to expand at a healthy CAGR of close to 7% through 2030.

Key Takeaways from Commercial Aquaculture Vaccines Market Study

  • Based on vaccine type, inactivated vaccines are the most profitable segment leading the market, and are expected to gain more than 70% of market revenue share over the forecast period.
  • Among all the pathogens, bacteria widely dominates (over 70%) due to high prevalence of bacterial infections among aquaculture.
  • Salmon is a widely dominating species in the market, due to rising production of the fish in leading developed countries, accounting for more than 55% of market share value.
  • The intraperitoneal route of administration is most preferred, due to high immune response elicitation of fish, and low stress and post-vaccination side effects.
  • Among the different end-users, fish farming companies will hold more than 80% of revenue share over the forecast period.
  • Europe is the largest market for commercial aquaculture vaccines, with Norway holding close to half of the share in this regional market.
  • Growth of the market is pegged at just 2.2% in 2021, but over the long term through 2030, it will get back to its normal growth trajectory of close to 7% CAGR.

“Increasing awareness of animal food pathogen transmission risks and rising prevalence of zoonotic infections are expected to boost demand for commercial aquaculture vaccines market,” says an analyst of Persistence Market Research

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32289

Trends in Commercial Aquaculture Vaccines Market

The manual vaccination process led to various adverse effects with high costs, owing to the lack of highly skilled and large number workforce needed, significant handling stress, and risk of post-vaccination infections. Thus, increased shift toward automated vaccination technology is expected to boost the commercial aquaculture vaccines market growth. For instance, Aqualife developed an automated Incubot 2, a mobile platform that would offer automated vaccination to smaller fish farms.

Rising demand for insurance in matured markets is an upcoming trend. Favourable insurance policies is an emerging trend to sustain the commercial aquaculture vaccines market across the globe. Introduction of third-party payers has supported the aquaculture sector globally, leading to a build-up of new sales channels for aquaculture vaccines.

For instance, according to the Food and Agriculture Organization of U. N., around 83 percent of fishers purchase insurance coverage for fish aquaculture farming.

Expansion of Manufacturing Capabilities & New Product Launches – Key Strategies for Market Players

Key players in the commercial aquaculture vaccines market are focussing on expanding their manufacturing capabilities to meet the unmet demand of commercial aquaculture vaccines. Given the consolidation in the market, top players are focusing on acquisitions at regional levels. The trend is being observed across various emerging regions.

  • For instance, in June 2020, Elanco received European Commission approval for the acquisition of Bayer Animal Health (US $ 5.17 Bn deal), and become the world’s second-largest animal health company. The combined business is expected to strengthen and accelerate the company’s innovation, portfolio, and product strategy.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the commercial aquaculture vaccines market in its latest study, presenting historical demand assessment of 2015 - 2019 and projections for 2020 - 2030, based on vaccine type, (DNA, subunit, attenuated, and inactivate ), pathogen (bacteria and virus), species (carp, turbot, salmon, tilapia, trout, sea bass, bream, and others), based on route of administration (intramuscular, intraperitoneal, immersion, and oral), and end user ( fish farming companies, fish veterinary clinics, and aquatic research institute), across seven key regions.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>
The Oral Hygiene Products Market To Oscillate Between CAGR Of 4.3% Wed, 07 Apr 2021 09:05:49 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700682.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700682.html persistencemarketresearch persistencemarketresearch

Oral hygiene products are used to treat dental plaque / biofilms, dental caries, gingivitis, halitosis, periodontitis and peri-implantitis. Increasing prevalence of these conditions across the world is expected to boost demand in the global oral hygiene products market. For instance, according to the Global Burden of Disease (GBD), severe periodontitis is the  6 th -most prevalent oral disease occurring worldwide, and accounts for  11.2%  prevalence rate.

Several initiatives for oral health awareness are being undertaken by leading oral hygiene market players. Major companies such as Colgate-Palmolive, Johnson & Johnson, Unilever, and Proctor & Gamble are focused on spreading awareness regarding good oral health and dental hygiene. For instance, the Indian Dental Association (IDA) drafted the National Oral Health Programme to address the burden of dental disease effectively for bringing about ‘optimal oral health’ for all by 2020.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/25915

Companies covered in Oral Hygiene Products Market Report

  • Colgate-Palmolive
  • Procter & Gamble
  • Unilever
  • GlaxoSmithKline
  • Johnson & Johnson
  • 3M Company
  • Dabur India Ltd.
  • Dentsply International Inc.
  • Ultradent Products, Inc.
  • Dentaid SL

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/25915

According to the latest report published by PersistenceMarketResearch, the global oral hygiene products market is anticipated to experience a steady CAGR of over 4% during the forecast period (2020–2030).

Key Takeaways from Oral Hygiene Products Market Study    

  • The toothpaste segment, under product, is expected to hold more than one-third revenue share in the global oral hygiene products market.
  • Dental plaque/biofilms and dental caries are leading indications and account for around 60% dental problems, followed by gingivitis. These segments are expected to grow at a higher rate as compared to other indications.
  • In terms of regional growth, East Asia and South Asia together hold more than 35% of the global oral hygiene products market value share. North America is a lucrative region with higher product adoption as compared to other regions.
  • The COVID-19 outbreak has created hindrances for the growth of the oral hygiene products market as most non-essential medical procedures are being postponed; this situation will persist in the first half of 2021 as well.

“Rising awareness regarding essential oral care and increase in prevalence of dental disorders will boost the global oral hygiene products market over the coming years. Wide distribution channel of oral hygiene products makes it more lucrative for expansion in the coming decade, where supermarkets/hypermarkets will be the largest contributor. Low capital cost required for manufacturing oral hygiene products will result in increasing number of market players in future,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/25915

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the oral hygiene products market are strengthening their product portfolios by launching new products.

  • Procter & Gamble launched new products in oral care such as Gum DetoxifyTM Toothpaste by Crest®, which is formulated for significantly improved gum health.

Various players in the oral hygiene products market are focusing on growth strategies such as expansion, collaborations, and agreement licences.

  • In Jan 2018, 3M and 3Shape announced a collaboration to advance the field of orthodontics via digital workflows, which intends to support indirect bonding, clear aligners, and other emerging digital orthodontic workflows.
  • In June 2016, Dentsply International Inc. announced the acquisition of MIS Implants Technologies Ltd., a manufacturer of dental implants.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the oral hygiene products market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, based on product (toothpaste, toothbrush, mouth wash / rinse, floss , teeth whitening, orthodontic wax, and denture cleansers & fixatives), indication (dental plaque / biofilms, dental caries, gingivitis, halitosis, periodontitis, and peri-implantitis), and distribution channel (hospital pharmacies, supermarkets / hypermarkets, drug stores, retail pharmacies, and e-Commerce), across seven key regions.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>
The Serum Free Media Market To Register A CAGR Of 7.3% Wed, 07 Apr 2021 09:05:27 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700681.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700681.html persistencemarketresearch persistencemarketresearch

Serum-free media gives more consistent cell growth and helps eliminate possible errors by minimizing the percentage of uneven growth among cell cultures. Consistency in cell culture coupled with superior cell growth with increased productivity makes it easier to use serum-free media for cell culture growth in biopharmaceutical production, research, and development.

Increasing focus on biopharmaceuticals to treat chronic diseases is fueling biopharmaceutical production. The contribution of biopharmaceuticals in the healthcare industry is rising due to superior efficacy as compared to  conventional drugs . Downstream processes are often regarded as a bottleneck of the biopharmaceutical industry, but it is increasing the usage of serum-free media for cell culture growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/15373

Companies covered in Serum Free Media Market Report

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza
  • Corning Incorporated
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • PAN Biotech
  • MP Biomedicals, LLC
  • PromoCell GmbH

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/15373

Increasing number of personalized targeted products, rise of advanced manufacturing technologies, continuously improving manufacturing scalability, and alternative downstream processes are some of the key drivers of increasing biopharmaceutical production. Moreover, production of serum-free media is largely concentrated in North America, Europe, and some parts of Asia Pacific, whereas, it has limited availability in untapped biopharmaceutical markets such as the Middle East & Africa, Latin America, and some countries of Asia.

Thus, it has huge scope for manufacturing to improve availability and provide cost-effective products in Latin America and MEA.

According to a latest report published by PersistenceMarketResearch , the global serum-free media market is expected to witness a CAGR of more than 7% during the forecast period (2020 – 2030), to close in on a valuation of US$ 3 Bn by the end of 2030.

 Key Takeaways from Serum-Free Media Market Study

  • The CHO cell media segment under media type is expected to hold more than twenty percent of revenue share in the serum-free media market.
  • By end user, biopharmaceutical companies held the highest market share in 2019. Serum-free media is significantly used in drug development and cell culture, which is anticipated to drive demand over the coming years.
  • Countries such as the U.S., Germany, India, and China are expected to experience significant growth in the global serum-free media market over the coming years, due to increase in drug development activities in these regions.
  • The COVID-19 outbreak has had a negative impact on the global serum-free media market, as a result of lockdowns and closing of manufacturing facilities across regions.

“Rise in biopharmaceutical industries and demand for cell therapies for cancer treatment will boost the global serum-free media market,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15373

Collaboration & Acquisitions – Key Strategies amongst Market Players

Leading players in the serum-free media market are strengthening their product portfolios by launching new products.

  • For instance, in March 2016, Lonza launched PowerCHO Advance™ Media for improved protein-production yields.

Various players in the serum-free media market are focusing on growth strategies such as collaborations and agreement licences.

  • In June 2018, Fujifilm completed the acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media.
  • In December 2019, Sartorius announced the acquisition of a majority stake in cell culture media specialist Biological Industries.
  • In May 2017, Lonza acquired cell and gene contract manufacturer PharmaCell.
  • In April  2017 , Thermo Fisher Scientific completed the acquisition of Brammer Bio, a viral vector manufacturer for gene and cell therapies.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on serum-free media in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2030 , on the basis of media type (protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media, immunology media, CHO cell media, and chemically-defined media), animal source (camelids and sharks), and end user (biopharmaceutical companies, clinical research organizations, and academic research centers), across seven key regions.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>
The Intubation Market To Witness A Growth Of 5%, To Reach Wed, 07 Apr 2021 09:05:04 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700680.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700680.html persistencemarketresearch persistencemarketresearch Rising number of surgical conditions due to trauma and chronic diseases such as diabetes, chronic respiratory, neurological, and renal diseases are expected to increase demand of medical intubation procedures, and subsequent use of intubation medical devices. For instance, increase in number of surgical procedures will have a direct impact on the sale of intubation products. According to a WHO study, in 2010, around 321.5 million surgical procedures were carried out to address the burden of different diseases for a global population of 6.9 billion.

 

Moreover, rising global adoption of intubation-based surgical procedures, extensive clinical research, and increasing launches of highly sophisticated intubation medical devices are responsible for the growth of the intubation market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/15676

Companies covered in Intubation Market Report

  • Medtronic
  • Deas S.R.L
  • Medis Medical
  • Smiths Medical
  • Flexicare Medical Limited

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/15676

Persistence Market Research predicts that the global intubation market will exhibit a 5% CAGR during the forecast period (2020-2030).

Key Takeaways from Intubation Market Study     

  • By product, the endotracheal tubes segment is expected to dominate the global intubation market during the forecast period, owing to high volume of surgical procedures that adopt the endotracheal intubation technique.
  • In terms of usage, the disposable intubation segment is expected to gain more than 3/4 of the intubation market share. Preference for disposable intubation medical devices is due to lower infection risk and convenience during intubation procedures.
  • Under the end user segmentation, hospitals and ambulatory surgical centres are expected to collectively gain more than 3/4 of the market by 2030.
  • North America is the highest revenue generating market by region, due to the launch of new products with rising adoption of intubation in surgical procedures, and an increasing elderly population. North America is expected to be followed by Europe in the global intubation market.
  • Lack of skilful workforce to perform intubation procedures and poorly developed healthcare infrastructures in developing economies are major challenges for the growth of the intubation market in these regions.
  • The COVID-19 pandemic will have a short-term negative impact on the global intubation market, owing to supply chain disruptions, reduced hospital-based procedures, and hampered research & development activities by companies in the intubation market. Due to the outbreak, many companies are focusing on finding a possible treatment option for COVID-19. Manufacturing industries around the world have been hampered due to global restrictions, causing unusual technology and business model disruption.

“Rising burden of surgical procedures and technological advancements are expected to drive the growth of the global intubation market,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15676

Disposable Intubation Products Dominate Market

Use of disposable medical devices in intubation and surgical procedures is increasing rapidly. Risk of infection with reused intubation devices and high cost associated with sterilization for reused products are projected to drive higher preference for disposable intubation devices. In addition, use of highly advanced biodegradable material for the manufacturing of intubation devices that facilitate the disposal of single-use intubation devices is pushing the trend of disposable intubation devices in the market.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the intubation market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product (airway management tubes and intubation accessories), usage (reusable and disposable), and end user (hospitals, ambulatory surgical centres, clinics, and research & diagnostic labs), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Autogenous Vaccines Market To Get Streamlined On A Healthy Front Between 2019 to 2029 Tue, 06 Apr 2021 12:41:47 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700468.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700468.html persistencemarketresearch persistencemarketresearch

Vaccination of animals is an essential part of animal health management. It helps to boost the immune system and keep animals safe from various bacterial and viral infections. Autogenous vaccines are most preferred for animal vaccination purposes. Federal guidelines state that an autogenous vaccine is made from a bacterial or viral strain of the diseased animal. Products made from these strains can only be marketed by veterinarian or farm owners from where they were isolated.

Over the years, there has been growing demand for autogenous vaccines that are derived from bacterial strains, owing to their greater efficacy as compared to viral strains. Salmonella, Staphylococcus, Haemophilus, and Mycoplasma are some of the commonly used bacterial strains to develop autogenous bacterial vaccines. Growing prevalence of bacterial infections among animals, preference toward autogenous vaccines over antibiotics, and increased funding and support for international animal disease eradication are likely to upswing demand for autogenous bacterial vaccines over the coming years.

According to a revised report published by Persistence Market Research, the autogenous vaccines market was valued over US$ 116 Mn in 2020, and is predicted to witness an impressive CAGR of 5.5% over the forecast period (2021-2031).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/29491

Companies covered in Autogenous Vaccines Market Report

  • Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
  • Phibro Animal Health
  • Elanco Animal Health
  • Ceva Santé Animale
  • ACE Laboratory Services (Apiam Animal Health)
  • Huvepharma, Inc.
  • AniCon Labor GmbH
  • Cambridge Technologies
  • Dyntec s. r. o
  • Hygieia Biological Laboratories
  • HIPRA
  • Vaxxinova
  • sanphar (ipeve)
  • Addison Biological Laboratory
  • Zoetis (PHARMAQ AS)
  • Barramundi Asia Pte Ltd.(UVAXX Asia)
  • Kennebec River Biosciences

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/29491

 Key Takeaways from Market Study

  • By type of strain, bacterial autogenous vaccines are expected to contribute to more than 1/3 revenue share in the market.
  • By end user, livestock farming companies will lead by acquiring over 45% of market share. This sector has witnessed the most adoption of autogenous vaccines as compared to other end users.
  • Europe holds around half of the global market share.
  • Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
  • COVID-19 outbreak in big economies is expected to negatively impact demand for autogenous vaccines owing to reduced healthcare center visits. Impact was also observed on vaccine production and transportation owing to travel restriction and lack of workforce at production centers.
  • The market in Thailand is projected to be the fastest-growing in the Asia Pacific region, and will expand at a CAGR above 5% through 2031.
  • The U.S. market holds a big portion of revenue, and its market share accounts for more than 90% in North America.

“Increasing preference for autogenous vaccines over antibiotics will catalyze market growth over the coming years,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/29491

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players manufacturing autogenous vaccines are collectively increasing their product ranges through strategic initiatives such as acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour market growth over the forecast period.

For instance,

  • In September 2019, Agri Labs (Huvepharma, Inc.) established a new fermentation plant in Peshtera, Southern Bulgaria.
  • In May 2017, Elanco Animal Health opened a new manufacturing facility for autogenous poultry vaccines in Winslow, Maine.
  • Agreement to acquire Bayer AG‘s animal health business by Elanco Animal Health in August 2019 is one of the major acquisitions in this space. This strategic move will help Elanco Animal Health enhance its market position.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the autogenous vaccines market in its latest study, presenting historical demand assessment of 2016-2020 and projections for 2021-2031, on the basis of strain (bacterial strain and viral strain) and end user (veterinary research institutes, livestock farming companies, and veterinary clinics and hospitals), across the five key regions of the world.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>
The Active Pharmaceutical Ingredient Market To Witness A Growth-Wise Disruption Between 2025 Tue, 06 Apr 2021 12:41:24 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700466.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/700466.html persistencemarketresearch persistencemarketresearch

Prevalence of chronic diseases is constantly on the rise across the world. This is leading to a major health burden on governments and the society in general. Out of these, cardiovascular diseases make up around half of the total deaths caused by chronic diseases. According to the World Health Organization, in 2016, ischemic heart disease and stroke accounted for around 27% of total deaths, worldwide. Chronic obstructive pulmonary disease was the third most cause of death in the same years. These non-communicable diseases were major causes of deaths globally, ranging from 37% in lower economies and 88% in countries with high income.

Rising cases of chronic diseases is surging the need for pharmaceutical products, thereby increasing the need for pharmaceutical ingredients (APIs), especially small molecules.

Persistence Market Research predicts that the global active pharmaceutical ingredients market to exhibit a CAGR above 4% over the forecast period (2021-2031).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/11260

Companies covered in Active Pharmaceutical Ingredient Marke Report

  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Hepalink Group
  • Lonza
  • Merck & Co. Inc.
  • Sandoz International GmbH
  • Aurobindo Pharma Limited
  • Fresenius Kabi LLC

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/11260

Key Takeaways from Market Study   

  • Non-controlled substances hold over half of the small molecule API market share, making them the predominant growth contributing factor.
  • Pharmaceutical and biopharmaceutical companies, combined, to contribute over 70% of the market revenue.
  • Major markets for active pharmaceutical ingredients to be East Asia, South Asia, North America, and Europe.
  • China and India to be the most lucrative markets for APIs.
  • Due to the impact of COVID-19, the API market saw a slight decline in growth in 2020, at 3.4%.

“Rising prevalence of chronic disorders and increasing research on small molecule APIs are expected to propel growth of the global active pharmaceutical ingredients market over the coming years,” says a Persistence Market Research analyst.

Access Full Report @https://www.persistencemarketresearch.com/checkout/11260

Advancements in API Manufacturing

API manufacturing will require implementation of continuous new technologies and tools to speed up the process and deliver consistent quality products. Hence, major players are highly focused on the production of optimized APIs with technological advancements in processes such as powder handling, lyophilization, process control, continuous flow chemistry, and process control.

Rise in Outsourcing to Merchant Companies

Even if big pharma players have established facilities for the production of APIs and pharma products, the trend of outsourcing is still on the rise. Many companies are outsourcing their requirements to cut costs on expensive equipment, manpower, and infrastructure. It is estimated that 40% of pharma products are manufactured by third-party vendors.

  • For instance, AstraZeneca used to have several manufacturing centers in North America, but currently, only 15% of its APIs are made in-house, and the company is looking to outsource all manufacturing overseas. From the last 20 years or so, directly sourcing APIs from China and India has increased due to the production capabilities of these countries. Also, stringent regulations in the West have attracted companies toward China and India.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the active pharmaceutical ingredients (API) market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031, on the basis of API (small molecules [controlled substances {natural opioids and semi-synthetic / synthetic opioids}, non-controlled substances {NSAIDs, anti-infective, antimicrobial, oral anti-diabetics, anti-hypertensive, and others}, and HPAPI], peptides & oligonucleotides, carbohydrate drugs, and steroidal drugs), end user (contract manufacturing organizations (CMOs), pharmaceuticals, contract development & manufacturing organizations (CDMOs), and compounding pharmacies), across seven key regions of the world.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

 

]]>